Annual CFO
$7.26 B
-$2.32 B-24.21%
31 December 2023
Summary:
Abbott Laboratories annual cash flow from operations is currently $7.26 billion, with the most recent change of -$2.32 billion (-24.21%) on 31 December 2023. During the last 3 years, it has fallen by -$640.00 million (-8.10%). ABT annual CFO is now -31.06% below its all-time high of $10.53 billion, reached on 31 December 2021.ABT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$2.71 B
+$745.00 M+38.01%
30 September 2024
Summary:
Abbott Laboratories quarterly cash flow from operations is currently $2.71 billion, with the most recent change of +$745.00 million (+38.01%) on 30 September 2024. Over the past year, it has increased by +$828.00 million (+44.11%). ABT quarterly CFO is now -28.78% below its all-time high of $3.80 billion, reached on 31 December 2020.ABT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$8.73 B
+$828.00 M+10.48%
30 September 2024
Summary:
Abbott Laboratories TTM cash flow from operations is currently $8.73 billion, with the most recent change of +$828.00 million (+10.48%) on 30 September 2024. Over the past year, it has increased by +$2.18 billion (+33.27%). ABT TTM CFO is now -22.51% below its all-time high of $11.26 billion, reached on 30 September 2021.ABT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -24.2% | +44.1% | +33.3% |
3 y3 years | -8.1% | +0.1% | -22.5% |
5 y5 years | +15.3% | +38.9% | +59.1% |
ABT Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -31.1% | at low | -11.8% | +163.9% | -22.5% | +33.3% |
5 y | 5 years | -31.1% | +18.3% | -28.8% | +278.3% | -22.5% | +59.1% |
alltime | all time | -31.1% | +656.4% | -28.8% | +3008.6% | -22.5% | +3912.9% |
Abbott Laboratories Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2.71 B(+38.0%) | $8.73 B(+10.5%) |
June 2024 | - | $1.96 B(+91.2%) | $7.90 B(+10.6%) |
Mar 2024 | - | $1.02 B(-66.3%) | $7.14 B(-1.6%) |
Dec 2023 | $7.26 B(-24.2%) | $3.04 B(+61.9%) | $7.26 B(+10.9%) |
Sept 2023 | - | $1.88 B(+56.0%) | $6.55 B(-12.1%) |
June 2023 | - | $1.20 B(+5.2%) | $7.45 B(-13.9%) |
Mar 2023 | - | $1.14 B(-50.9%) | $8.66 B(-9.6%) |
Dec 2022 | $9.58 B(-9.0%) | $2.33 B(-16.3%) | $9.58 B(-7.2%) |
Sept 2022 | - | $2.78 B(+15.4%) | $10.32 B(+0.8%) |
June 2022 | - | $2.41 B(+16.7%) | $10.24 B(+2.8%) |
Mar 2022 | - | $2.06 B(-32.7%) | $9.96 B(-5.4%) |
Dec 2021 | $10.53 B(+33.3%) | $3.07 B(+13.6%) | $10.53 B(-6.5%) |
Sept 2021 | - | $2.70 B(+26.9%) | $11.26 B(+6.0%) |
June 2021 | - | $2.13 B(-19.3%) | $10.63 B(+8.2%) |
Mar 2021 | - | $2.64 B(-30.6%) | $9.82 B(+24.3%) |
Dec 2020 | $7.90 B(+28.8%) | $3.80 B(+83.8%) | $7.90 B(+21.2%) |
Sept 2020 | - | $2.07 B(+56.3%) | $6.52 B(+1.8%) |
June 2020 | - | $1.32 B(+84.9%) | $6.40 B(+4.3%) |
Mar 2020 | - | $715.00 M(-70.4%) | $6.14 B(+0.0%) |
Dec 2019 | $6.14 B(-2.6%) | $2.42 B(+24.0%) | $6.14 B(+11.9%) |
Sept 2019 | - | $1.95 B(+83.8%) | $5.49 B(-4.1%) |
June 2019 | - | $1.06 B(+48.9%) | $5.72 B(-3.1%) |
Mar 2019 | - | $712.00 M(-59.7%) | $5.90 B(-6.3%) |
Dec 2018 | $6.30 B(+13.1%) | $1.76 B(-19.1%) | $6.30 B(+2.0%) |
Sept 2018 | - | $2.18 B(+75.5%) | $6.17 B(+3.0%) |
June 2018 | - | $1.24 B(+12.3%) | $6.00 B(-1.8%) |
Mar 2018 | - | $1.11 B(-32.4%) | $6.10 B(+9.6%) |
Dec 2017 | $5.57 B(+73.9%) | $1.64 B(-18.2%) | $5.57 B(+9.2%) |
Sept 2017 | - | $2.00 B(+48.4%) | $5.10 B(+18.3%) |
June 2017 | - | $1.35 B(+135.4%) | $4.31 B(+11.4%) |
Mar 2017 | - | $574.00 M(-50.9%) | $3.87 B(+20.8%) |
Dec 2016 | $3.20 B(+8.0%) | $1.17 B(-3.9%) | $3.20 B(+12.0%) |
Sept 2016 | - | $1.22 B(+33.9%) | $2.86 B(+0.8%) |
June 2016 | - | $909.00 M(-1077.4%) | $2.84 B(-1.1%) |
Mar 2016 | - | -$93.00 M(-111.2%) | $2.87 B(-3.2%) |
Dec 2015 | $2.97 B(-19.3%) | $828.00 M(-30.7%) | $2.97 B(-12.1%) |
Sept 2015 | - | $1.20 B(+27.0%) | $3.38 B(-0.2%) |
June 2015 | - | $941.00 M(>+9900.0%) | $3.38 B(+1.2%) |
Mar 2015 | - | $2.00 M(-99.8%) | $3.34 B(-9.1%) |
Dec 2014 | $3.67 B(+10.6%) | $1.24 B(+3.1%) | $3.67 B(-9.5%) |
Sept 2014 | - | $1.20 B(+33.4%) | $4.06 B(+20.1%) |
June 2014 | - | $900.00 M(+167.9%) | $3.38 B(+5.7%) |
Mar 2014 | - | $336.00 M(-79.3%) | $3.20 B(-3.7%) |
Dec 2013 | $3.32 B(-64.3%) | $1.63 B(+211.3%) | $3.32 B(+3.8%) |
Sept 2013 | - | $522.00 M(-27.2%) | $3.20 B(-48.4%) |
June 2013 | - | $717.00 M(+55.9%) | $6.20 B(-17.9%) |
Mar 2013 | - | $460.00 M(-69.4%) | $7.55 B(-18.9%) |
Dec 2012 | $9.31 B(+3.8%) | $1.50 B(-57.3%) | $9.31 B(+1.1%) |
Sept 2012 | - | $3.52 B(+70.3%) | $9.21 B(+5.3%) |
June 2012 | - | $2.07 B(-7.1%) | $8.75 B(-4.8%) |
Mar 2012 | - | $2.22 B(+58.8%) | $9.18 B(+2.4%) |
Dec 2011 | $8.97 B(+2.7%) | $1.40 B(-54.1%) | $8.97 B(-9.3%) |
Sept 2011 | - | $3.05 B(+22.0%) | $9.89 B(+5.4%) |
June 2011 | - | $2.50 B(+24.5%) | $9.38 B(+1.7%) |
Mar 2011 | - | $2.01 B(-13.2%) | $9.22 B(+5.6%) |
Dec 2010 | $8.74 B(+20.1%) | $2.32 B(-9.1%) | $8.74 B(+5.9%) |
Sept 2010 | - | $2.55 B(+8.5%) | $8.25 B(-5.5%) |
June 2010 | - | $2.35 B(+54.2%) | $8.73 B(+7.8%) |
Mar 2010 | - | $1.52 B(-16.9%) | $8.10 B(+11.3%) |
Dec 2009 | $7.28 B(+4.0%) | $1.83 B(-39.5%) | $7.28 B(+9.0%) |
Sept 2009 | - | $3.03 B(+76.8%) | $6.68 B(+5.2%) |
June 2009 | - | $1.71 B(+145.3%) | $6.34 B(-0.7%) |
Mar 2009 | - | $698.72 M(-43.3%) | $6.39 B(-8.7%) |
Dec 2008 | $6.99 B(+34.9%) | $1.23 B(-54.3%) | $6.99 B(+2.7%) |
Sept 2008 | - | $2.70 B(+53.5%) | $6.81 B(+20.5%) |
June 2008 | - | $1.76 B(+34.7%) | $5.65 B(+4.0%) |
Mar 2008 | - | $1.31 B(+24.3%) | $5.43 B(+4.8%) |
Dec 2007 | $5.18 B | $1.05 B(-31.7%) | $5.18 B(-4.4%) |
Sept 2007 | - | $1.54 B(-0.1%) | $5.42 B(+4.9%) |
June 2007 | - | $1.54 B(+45.7%) | $5.17 B(-0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $1.06 B(-18.0%) | $5.20 B(-2.4%) |
Dec 2006 | $5.33 B(+3.0%) | $1.29 B(+0.3%) | $5.33 B(-1.2%) |
Sept 2006 | - | $1.28 B(-18.3%) | $5.39 B(-2.5%) |
June 2006 | - | $1.57 B(+32.9%) | $5.53 B(-5.0%) |
Mar 2006 | - | $1.18 B(-12.4%) | $5.82 B(+12.6%) |
Dec 2005 | $5.17 B(+15.8%) | $1.35 B(-5.2%) | $5.17 B(+10.4%) |
Sept 2005 | - | $1.42 B(-23.6%) | $4.68 B(+13.6%) |
June 2005 | - | $1.86 B(+249.3%) | $4.13 B(+11.4%) |
Mar 2005 | - | $533.73 M(-38.1%) | $3.70 B(-17.1%) |
Dec 2004 | $4.47 B(+25.7%) | $861.69 M(-0.5%) | $4.47 B(+6.8%) |
Sept 2004 | - | $865.78 M(-40.0%) | $4.18 B(-3.9%) |
June 2004 | - | $1.44 B(+11.3%) | $4.35 B(+11.5%) |
Mar 2004 | - | $1.30 B(+123.9%) | $3.91 B(+9.9%) |
Dec 2003 | $3.55 B(-11.0%) | $578.97 M(-44.1%) | $3.55 B(-10.8%) |
Sept 2003 | - | $1.04 B(+4.0%) | $3.98 B(+3.5%) |
June 2003 | - | $995.61 M(+5.6%) | $3.85 B(+2.0%) |
Mar 2003 | - | $943.02 M(-6.5%) | $3.77 B(-5.5%) |
Dec 2002 | $3.99 B(+11.9%) | $1.01 B(+12.0%) | $3.99 B(+3.1%) |
Sept 2002 | - | $900.93 M(-2.0%) | $3.87 B(-6.8%) |
June 2002 | - | $918.87 M(-21.0%) | $4.15 B(+9.0%) |
Mar 2002 | - | $1.16 B(+31.1%) | $3.81 B(+6.9%) |
Dec 2001 | $3.57 B(+15.1%) | $887.39 M(-25.1%) | $3.57 B(+3.3%) |
Sept 2001 | - | $1.18 B(+105.4%) | $3.45 B(+17.2%) |
June 2001 | - | $576.51 M(-37.2%) | $2.95 B(-19.0%) |
Mar 2001 | - | $918.57 M(+18.6%) | $3.64 B(+17.4%) |
Dec 2000 | $3.10 B(+5.5%) | $774.18 M(+14.2%) | $3.10 B(+16.8%) |
Sept 2000 | - | $677.88 M(-46.5%) | $2.65 B(-10.7%) |
June 2000 | - | $1.27 B(+233.6%) | $2.97 B(+19.0%) |
Mar 2000 | - | $379.96 M(+15.7%) | $2.50 B(-15.0%) |
Dec 1999 | $2.94 B(+5.7%) | $328.46 M(-67.0%) | $2.94 B(-5.9%) |
Sept 1999 | - | $995.94 M(+25.6%) | $3.12 B(+15.8%) |
June 1999 | - | $792.96 M(-3.3%) | $2.70 B(-0.9%) |
Mar 1999 | - | $820.14 M(+60.2%) | $2.72 B(-2.2%) |
Dec 1998 | $2.78 B(+4.5%) | $512.10 M(-10.2%) | $2.78 B(-4.7%) |
Sept 1998 | - | $570.46 M(-30.1%) | $2.92 B(-2.5%) |
June 1998 | - | $816.24 M(-7.4%) | $2.99 B(+8.6%) |
Mar 1998 | - | $881.40 M(+35.6%) | $2.76 B(+3.6%) |
Dec 1997 | $2.66 B(+11.7%) | $649.90 M(+0.6%) | $2.66 B(+3.1%) |
Sept 1997 | - | $646.29 M(+11.6%) | $2.58 B(+0.5%) |
June 1997 | - | $579.28 M(-26.2%) | $2.57 B(+3.4%) |
Mar 1997 | - | $784.63 M(+37.5%) | $2.48 B(+4.2%) |
Dec 1996 | $2.38 B(+21.2%) | $570.56 M(-9.8%) | $2.38 B(+7.2%) |
Sept 1996 | - | $632.54 M(+27.8%) | $2.22 B(+5.4%) |
June 1996 | - | $494.80 M(-27.7%) | $2.11 B(-1.5%) |
Mar 1996 | - | $684.20 M(+66.4%) | $2.14 B(+8.9%) |
Dec 1995 | $1.97 B(-11.1%) | $411.18 M(-20.8%) | $1.97 B(-8.4%) |
Sept 1995 | - | $519.18 M(-1.5%) | $2.15 B(-3.6%) |
June 1995 | - | $526.89 M(+3.7%) | $2.23 B(+2.5%) |
Mar 1995 | - | $508.33 M(-14.1%) | $2.17 B(-1.7%) |
Dec 1994 | $2.21 B(+19.8%) | $591.69 M(-1.5%) | $2.21 B(+5.7%) |
Sept 1994 | - | $600.46 M(+26.9%) | $2.09 B(+1.3%) |
June 1994 | - | $473.14 M(-13.5%) | $2.06 B(+5.5%) |
Mar 1994 | - | $546.85 M(+15.8%) | $1.96 B(+6.0%) |
Dec 1993 | $1.85 B(+33.0%) | $472.11 M(-17.6%) | $1.85 B(-1.9%) |
Sept 1993 | - | $572.70 M(+56.4%) | $1.88 B(+19.3%) |
June 1993 | - | $366.10 M(-16.0%) | $1.58 B(+1.4%) |
Mar 1993 | - | $436.00 M(-14.2%) | $1.56 B(+12.1%) |
Dec 1992 | $1.39 B(-4.4%) | $508.40 M(+90.1%) | $1.39 B(+7.3%) |
Sept 1992 | - | $267.50 M(-22.4%) | $1.29 B(-9.8%) |
June 1992 | - | $344.60 M(+28.4%) | $1.44 B(-2.8%) |
Mar 1992 | - | $268.30 M(-35.2%) | $1.48 B(+1.6%) |
Dec 1991 | $1.45 B(+21.0%) | $414.20 M(+1.4%) | $1.45 B(+2.8%) |
Sept 1991 | - | $408.30 M(+6.0%) | $1.41 B(+3.5%) |
June 1991 | - | $385.30 M(+57.0%) | $1.37 B(+11.2%) |
Mar 1991 | - | $245.40 M(-34.5%) | $1.23 B(+2.3%) |
Dec 1990 | $1.20 B(+25.1%) | $374.90 M(+4.0%) | $1.20 B(+45.4%) |
Sept 1990 | - | $360.50 M(+45.4%) | $826.00 M(+77.4%) |
June 1990 | - | $248.00 M(+14.0%) | $465.50 M(+114.0%) |
Mar 1990 | - | $217.50 M | $217.50 M |
Dec 1989 | $959.90 M | - | - |
FAQ
- What is Abbott Laboratories annual cash flow from operations?
- What is the all time high annual CFO for Abbott Laboratories?
- What is Abbott Laboratories annual CFO year-on-year change?
- What is Abbott Laboratories quarterly cash flow from operations?
- What is the all time high quarterly CFO for Abbott Laboratories?
- What is Abbott Laboratories quarterly CFO year-on-year change?
- What is Abbott Laboratories TTM cash flow from operations?
- What is the all time high TTM CFO for Abbott Laboratories?
- What is Abbott Laboratories TTM CFO year-on-year change?
What is Abbott Laboratories annual cash flow from operations?
The current annual CFO of ABT is $7.26 B
What is the all time high annual CFO for Abbott Laboratories?
Abbott Laboratories all-time high annual cash flow from operations is $10.53 B
What is Abbott Laboratories annual CFO year-on-year change?
Over the past year, ABT annual cash flow from operations has changed by -$2.32 B (-24.21%)
What is Abbott Laboratories quarterly cash flow from operations?
The current quarterly CFO of ABT is $2.71 B
What is the all time high quarterly CFO for Abbott Laboratories?
Abbott Laboratories all-time high quarterly cash flow from operations is $3.80 B
What is Abbott Laboratories quarterly CFO year-on-year change?
Over the past year, ABT quarterly cash flow from operations has changed by +$828.00 M (+44.11%)
What is Abbott Laboratories TTM cash flow from operations?
The current TTM CFO of ABT is $8.73 B
What is the all time high TTM CFO for Abbott Laboratories?
Abbott Laboratories all-time high TTM cash flow from operations is $11.26 B
What is Abbott Laboratories TTM CFO year-on-year change?
Over the past year, ABT TTM cash flow from operations has changed by +$2.18 B (+33.27%)